Radiological.ai

Compare · Gleamer

Gleamer alternative that flags, prioritizes and drafts across the whole read

The short answer

Gleamer is a French radiology AI company best known for BoneView, which supports fracture and bone trauma reading on X-ray, alongside ChestView for chest radiographs and its breast imaging product. RadNet acquired Gleamer in March 2026 and folded it into its DeepHealth AI business, so US buyers are now evaluating it as part of a larger portfolio rather than as an independent vendor. It is deep, per-exam detection on radiography, deployed widely in Europe. Radiological.ai is a whole-read alternative: one assistant that flags suspected findings, prioritizes the worklist and drafts the structured report across X-ray, CT and MRI. It is decision support, and the radiologist reviews, edits and signs every study.

Gleamer built its reputation on musculoskeletal radiography, and it is genuinely good at it. BoneView supports the trauma X-ray read for fractures, dislocations, effusions and focal bone lesions, ChestView covers chest radiographs, and the company reports deployment across thousands of institutions in dozens of countries. If your bottleneck is a high-volume trauma or ED X-ray list, that focus is exactly the point.

The groups that go looking for a Gleamer alternative are usually running a broader list. They read the trauma films, but they also read head CTs, abdominal studies and MRI, and each additional Gleamer product is another module in the suite. They also tend to want the report drafted, not only the finding flagged. Radiological.ai is built for that shape: one assistant that flags suspected findings for a second look, prioritizes the worklist so urgent studies do not wait, and drafts the structured report into your template, across X-ray, CT and MRI in a single pane. It is decision support, and you review and sign every study.

Last updated July 2026

The Reading Station

Worklist

SERIES 1 · AX
SLICE 24/64
SAMPLE STUDY
NOT FOR DIAGNOSTIC USE
W 80 · L 40
ILLUSTRATIVE SAMPLE

Structured report

Draft

Run the assistant to draft this report for review.

You review & sign

Illustrative sample · not a real patient study, not a diagnosis

Drafted in · you review & sign Worklist re-prioritized

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional judgment.

See the comparison

Flag · prioritize · draft · you review and sign

Gleamer is strong per-exam detection on radiography, deepest on musculoskeletal trauma X-ray via BoneView with wide European deployment; Radiological.ai is a whole-read assistant that flags suspected findings, prioritizes the worklist and drafts the structured report across X-ray, CT and MRI in one pane.

Side by side

Radiological.ai vs Gleamer, honestly

A fair look at what each does well. Both are capable tools. Here is where they differ.

What matters Radiological.ai Gleamer
Primary focus Whole-read workflow: flag, prioritize and draft in one assistant Per-exam detection, deepest on musculoskeletal trauma X-ray
Modality coverage X-ray, CT and MRI across common study types in one pane Radiography focused, with separate products per exam area
Product shape One assistant, one contract, one integration A suite of products (BoneView, ChestView and others) licensed per module
Structured report drafting Drafts the structured report into your template for you to edit and sign Centered on detection output rather than report drafting
Worklist prioritization Triages the combined worklist so urgent studies surface first Flags findings on the exam; queue triage is not the core product
Regulatory status Decision support; we make no regulatory-status claims on this site Publishes regulatory clearances and peer-reviewed studies for its products
Pricing Published plans on our pricing page Not published; quoted per institution and per module
Best suited for Groups wanting one assistant across a mixed reading list High-volume trauma and ED radiography lists

Comparison reflects general, publicly understood positioning. Capabilities change, so check each product for the latest.

One thing to factor into a Gleamer evaluation in 2026 is ownership. RadNet acquired Gleamer in March 2026 and folded it into DeepHealth, which also launched its own reporting product that June, so roadmap and integration questions now run through a larger parent that operates US imaging centers. Our DeepHealth alternative page covers what that consolidation means, and the RadNet ownership question covers what to ask when your software vendor also competes with you.

On the product side, the comparison usually comes down to how much of the reading list one contract covers. AI fracture detection covers the trauma X-ray use case Gleamer is strongest on, and AI chest X-ray covers the other radiography list. Groups buying detection one exam type at a time usually end up on the alternatives hub working out how many contracts they are actually running.

Why groups pick Radiological.ai

One assistant across the whole read

One assistant, not a module per exam

Gleamer sells depth per exam area, so covering more of your list means licensing more products. Radiological.ai spreads decision support across X-ray, CT and MRI in one contract and one integration, which is usually the difference groups are weighing.

The report, not just the flag

A detection product marks the finding and stops. The assistant also prioritizes the worklist and drafts the structured report into your template, so the radiologist starts from an ordered queue and an edit rather than a flag and a blank page.

Decision support, you always sign

Every flag is a prompt to look and every report is a draft. The responsible radiologist reviews, edits and signs each study, and we publish no accuracy figures and make no regulatory-status claims.

Good questions

Gleamer vs Radiological.ai, answered

If your reading list spans X-ray, CT and MRI and you want the report drafted rather than only the finding flagged, yes. Radiological.ai covers the whole read in one assistant instead of a module per exam area. If your bottleneck is specifically a high-volume trauma X-ray list, BoneView is purpose-built for exactly that and worth comparing head to head.
RadNet. The US imaging operator announced the acquisition of Gleamer in March 2026 and placed it inside DeepHealth, its AI business. For a buyer that changes two things worth asking about: whether the roadmap for the product you are licensing still serves independent groups, and what happens to your pricing and support tier now that the vendor sits inside a company that also operates imaging centers.
BoneView is Gleamer flagship product, an AI tool that supports the trauma radiograph read by marking suspected fractures, dislocations, effusions and focal bone lesions on X-rays of the limbs, pelvis, spine and rib cage. It is used mainly in emergency and trauma settings, and Gleamer publishes clearances and peer-reviewed studies for it.
Gleamer does not publish pricing. Like most radiology AI vendors it quotes per institution, and the number depends on which products you license, your volume and your deployment. Ask for a fully loaded first-year figure that includes integration, and ask specifically which modules that figure covers. Our plans are published on the pricing page.
It flags suspected findings on radiographs as part of covering the whole read, and drafts the structured report. What we do not do is claim detection performance on fractures or any other finding: we publish no accuracy figures and make no regulatory-status claims. If fracture detection performance is your deciding factor, compare the published evidence for the dedicated products directly.

More comparisons

See how Radiological.ai compares

vs Aidoc

Aidoc alternative

One assistant across the whole read, not acute triage alone.

vs Rad AI

Rad AI alternative

Drafting plus flagging and triage, in one assistant.

vs DeepHealth

DeepHealth alternative

Reporting AI without buying it from a competitor.

vs Fluency for Imaging

PowerScribe vs Fluency for Imaging

The two reporting platforms most US groups actually shortlist.

vs Annalise.ai

Annalise.ai alternative

Finding flags plus triage and drafting, together.

vs Nuance PowerScribe

Nuance PowerScribe alternative

More than dictation: flagging, triage and drafting.

vs Qure.ai

Qure.ai alternative

Flags plus triage and drafting, in one assistant.

vs Viz.ai

Viz.ai alternative

Beyond acute stroke triage, across the whole read.

vs Nuance DAX

Nuance DAX alternative

Built for the read, not for the patient conversation.

vs Lunit

Lunit alternative

One assistant across the whole read, not detection on two modalities.

vs PowerScribe One

PowerScribe One vs 360

What actually changes in the cloud move, and the third option.

vs Sirona Medical

Sirona Medical alternative

Add the assistant to the PACS you already run, without replacing the stack.

vs RapidAI

RapidAI alternative

Past the stroke pathway, across the whole reading list.

vs Dragon Medical One

Dragon Medical One pricing

Microsoft publishes no price. Here are 25 real federal contracts that do.

vs PowerScribe

PowerScribe pricing

No list price exists. Here are the only verifiable numbers that do.

vs PowerScribe

PowerScribe templates

What AutoText actually is, how to get yours out, and what survives a migration.

vs RADPAIR and PowerScribe

RadPair vs PowerScribe

Three ways to write the report, compared on what each one actually replaces.

vs Aidoc and Viz.ai

Aidoc vs Viz.ai

Three acute triage platforms, compared on what they were each built to do.

From the blog: what the PowerScribe 360 end of life means for radiology groups, how much radiology AI costs, and the full comparison of the best AI radiology software in 2026.

See how Radiological.ai reads alongside your group

One assistant that flags suspected findings, prioritizes the worklist, and drafts the structured report on X-ray, CT and MRI. You review and sign every study.

See pricing

Decision support for qualified clinicians. Radiological.ai does not provide a diagnosis and is not a substitute for professional medical judgment.